Transfection Reagents And Equipment Market Report 2026

Transfection Reagents And Equipment Market Overview

• Transfection Reagents And Equipment market size has reached to $1.74 billion in 2025 • Expected to grow to $2.97 billion in 2030 at a compound annual growth rate (CAGR) of 11.3% • Growth Driver: Rising Cancer Rates Fuel Growth In Transfection Reagents And Equipment Market • Market Trend: FDA Recognition Boosts Next-Generation Reagents For Scalable Gene Therapy Production • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Transfection Reagents And Equipment Market?

Transfection reagents refer to substances or kits used to introduce foreign genetic material, such as DNA or RNA, into cells. These reagents facilitate the delivery of nucleic acids into cells, allowing researchers to study gene expression, manipulate gene function, or produce recombinant proteins. The main types of products in transfection reagents and equipment are instruments and reagents, and kits. Transfection instruments refer to specialized laboratory instruments designed to facilitate the delivery of foreign nucleic acids (such as DNA or RNA) into cells during the process of transfection. The various molecules include plasmid DNA, DNA oligonucleotides, small interfering RNA (siRNA), proteins, ribonucleoprotein complexes (RNPs), and others. The various organisms are bacteria, mammalian cells, fungi, plants, and viruses. These are used by various end-users such as biopharma, contract research organizations (CROs), contract manufacturing organizations (CMOs), contract development and manufacturing organizations (CDMOs), academia, hospitals, clinical labs, and others.

What Is The Transfection Reagents And Equipment Market Growth Forecast?

The transfection reagents and equipment market size is expected to see rapid growth in the next few years. It will grow to $2.97 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to increasing adoption of CRISPR and gene therapy research, rising demand for scalable transfection platforms, expansion of biopharmaceutical pipeline development, growing investment in precision medicine, increasing automation in life science laboratories. Major trends in the forecast period include increasing adoption of high-efficiency transfection reagents, rising demand for gene editing-compatible delivery systems, growing use of non-viral transfection methods, expansion of automated transfection instruments, enhanced focus on cell-type specific transfection solutions.

Global Transfection Reagents And Equipment Market Segmentation

1) By Product: Instruments, Reagent And Kits 2) By Types Of Molecule: Plasmid DNA, DNA Oligonucleotides, Small Interfering RNA (SiRNA), Proteins, Ribonucleoprotein Complexes (RNPs), Other Molecules 3) By End User: Biopharma, Contract Research Organizations (CROs), Academia Subsegments: 1) By Instruments: Electroporation Systems, Microinjection Systems, Particle Bombardment Systems 2) By Reagent And Kits: Lipid-Based Transfection Reagents, Polymer-Based Transfection Reagents, Protein-Based Transfection Reagents, Nucleic Acid Delivery Kits

What Is The Driver Of The Transfection Reagents And Equipment Market?

The rising number of cancer patients worldwide is expected to propel the growth of the transfection reagents and equipment market going forward. Cancer is a group of diseases in which cells grow abnormally and uncontrollably. Transfection reagents are commonly used in cancer research to introduce foreign genetic material, such as plasmid DNA or RNA molecules, and allow researchers to investigate various aspects of cancer biology, such as gene expression studies, gene silencing, drug screening, and target validation. For instance, in July 2024, according to the projections published by Cancer Research UK, a UK-based cancer charity, cancer incidence rates in the United Kingdom are projected to increase for most types between 2023-2025 and 2038-2040, with rises ranging from less than 1% for breast cancer to 50% for eye cancer, while a smaller number of cancers are expected to see a decline, with reductions ranging from 2% for lung cancer to 27% for mesothelioma. Therefore, the rising number of cancer patients worldwide drives the growth of the transfection reagents and equipment industry.

Key Players In The Global Transfection Reagents And Equipment Market

Major companies operating in the transfection reagents and equipment market are Thermo Fisher Scientific Inc., Promega Corporation, Qiagen N.V., Bio-Rad Laboratories Inc., MaxCyte Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, OriGene Technologies Inc., Altogen Biosystems, Applied Biological Materials Inc., Bex Co. Ltd., Takara Bio Inc., Polyplus-transfection SA, Sigma-Aldrich Corporation, Transfection Technologies Inc., Viromer, ABM Inc., chemicell GmbH, Genlantis, Biontech Laboratories GmbH, Jena Bioscience GmbH, PromoCell GmbH, PerkinElmer Inc., Sartorius AG, Hoffmann-La Roche Ltd., Bio-Techne Corporation, Biotium Inc., Cell Applications Inc.

Global Transfection Reagents And Equipment Market Trends and Insights

Major companies operating in the transfection reagents and equipment market are focusing on developing innovative advancements such as GMP-grade AAV transfection reagents to improve viral vector production efficiency and support large-scale gene therapy manufacturing. A GMP-grade AAV transfection reagent is a regulatory-compliant chemical formulation designed to enable high-efficiency genetic material delivery into suspension cell cultures for the scalable production of recombinant adeno-associated virus vectors. For instance, in July 2025, Yeasen Biotechnology, a China-based biotechnology manufacturer, received U.S. Food and Drug Administration Drug Master File acceptance for its UltraAAV PEI Transfection Reagent—GMP grade. The reagent demonstrates substantially higher viral titers and significantly improved full capsid ratios across multiple adeno-associated virus serotypes, offering superior performance relative to standard formulations. It further enhances manufacturing efficiency by achieving comparable vector yields with reduced reagent usage while adhering to stringent regulatory and quality requirements suitable for clinical and commercial gene therapy production.

What Are Latest Mergers And Acquisitions In The Transfection Reagents And Equipment Market?

In March 2023, Sartorius AG., a Germany-based analytical laboratory instrument manufacturing company, acquired Polyplus-Transfection SA. for $2.6 billion. Through this acquisition, Sartorius AG aims to establish a strong position in the rapidly growing cell and gene therapy markets, grow its business, and meet the increasing demand for cell and gene therapies. Polyplus-Transfection SA. is a France-based biotechnology company that develops transfection reagents and equipment.

Regional Outlook

North America was the largest region in the transfection reagents and equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Transfection Reagents And Equipment Market?

The transfection reagents and equipment market consists of sales of lipid-based transfection reagents, cationic polymer-based transfection reagents, calcium phosphate-based transfection reagents, viral transduction tools, transfection control plasmids, transfection validation tools, and electroporation systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.